Phase 2 Alzheimer's Disease Trial, Not Yet Recruiting
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- People aged between 55 and 85 years old.
- People who have been diagnosed with mild to moderate Alzheimer's disease, based on recognised international diagnostic guidelines.
- People whose score on a standard memory and thinking test (called the MMSE) falls between 10 and 24 out of 30.
- People who show signs of difficulty with memory for recent events, measured as being notably below what is typical for their age group.
- People who are taking Alzheimer's medications at a consistent, unchanged dose.
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- People who have another significant brain or mental health condition.
- People whose brain scans (MRI) show notable abnormalities related to amyloid, a protein linked to Alzheimer's disease (confirm with trial site).
- People who have recently used experimental or investigational drugs.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 00989141005277
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
This date has passed while the registry still lists the trial as open to participants. Sponsors often update a trial's status without revising its projected end date, so it may well still be recruiting — but the record is out of date in at least one respect. Check with the study contact before relying on either.
Primary endpoints
Alzheimer's Disease Assessment Scale - Cognitive Subscale (ADAS-Cog13)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 8 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.